Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cannabidiol
Pharma
Jazz's Epidiolex fails trial in treatment-resistant epilepsies
Jazz Pharmaceuticals' cannabidiol-based seizure drug Epidiolex has stumbled on its quest to secure approval in Japan.
Fraiser Kansteiner
Aug 23, 2024 10:18am
NICE signs off on reimbursement for Jazz's cannabinoid med
Feb 1, 2023 11:52am
PureTech readies oral CBD capsule for clinic to challenge Jazz
Dec 1, 2022 12:03pm
Jazz must hash new plan for cannabis drug after MS trial failure
Jun 28, 2022 10:35am
RLS bags $10M to trial dry powder inhaled CBD in anxiety
Apr 12, 2022 8:00am
GW plots path to new drug approvals as Epidiolex coasts
Nov 5, 2020 11:14am
